Medication is sometimes necessary to treat eye conditions and vision problems. Of course, this is highly dependent on the ...

Shares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve analysts that are presently covering the stock, Marketbeat.com reports. One ...

U.S. economy grows solid 2.3% from October to December, 2.8% for full year 2024 ...